Mechanistic description
Use precise gene editing (base editing or prime editing) to convert pathogenic R112 back to C112 in APOE4 carriers, eliminating aberrant domain interaction and restoring normal APOE function
Debate provenance: derived from debate sess_sda-2026-04-01-gap-010 on question: APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms APOE, APOE4, C112, Cysteine, R112, Substitution, Targeted. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Targeted Cysteine Substitution Gene Therapy. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-c417be996390
@misc{scidex_hypothesis_hdebatec,
title = {Targeted Cysteine Substitution Gene Therapy},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-c417be996390},
note = {SciDEX artifact hypothesis:h-debate-c417be996390}
}